longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Mizuho Securities Keeps Their Buy Rating on Assembly Biosciences (ASMB)

Tip Ranks
Jun 12, 2026 at 07:15 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

In a report released today, from Mizuho Securities maintained a Buy rating on Assembly Biosciences, with a price target of $45.00.Introducing TipRanks MCP for Agents Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. Designed for personal research, portfolio monitoring, and AI-assisted investment workflows. In a report released on June 3, H.C. Wainwright also reiterated a Buy rating on the stock with a $50.00 price target.

In a report released today, from Mizuho Securities maintained a Buy rating on Assembly Biosciences, with a price target of $45.00.

Introducing TipRanks MCP for Agents

  • Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
  • Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.

In a report released on June 3, H.C. Wainwright also reiterated a Buy rating on the stock with a $50.00 price target.

Login to unlock491characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Assembly Biosciences

Assembly Biosciences

USASMB

-2.82%

Mizuho Financial

Mizuho Financial

USMFG

LongbridgeAI